biosimilarslawblog.com
FDA Anticipates New Draft Biosimilar Guidances | Biosimilars Law Blog
http://www.biosimilarslawblog.com/2014/02/06/fda-anticipates-new-draft-biosimilar-guidances
With more than 100 lawyers serving the pharmaceutical and biotechnology sectors, we offer timely, effective counsel on a wide variety of matters. Continue Reading ». FDA Anticipates New Draft Biosimilar Guidances. February 6th, 2014. By Marie A. Vodicka. Posted in News and Events. FDA Anticipates New Draft Biosimilar Guidances. Including biosimilars in the release of expected 2014 CDER draft guidance documents. Clinical Pharmacology Data to Support a Demonstration of Biosimilarity to a Reference Product.
biosimilarslawblog.com
biosimilar | Biosimilars Law Blog
http://www.biosimilarslawblog.com/tag/biosimilar
With more than 100 lawyers serving the pharmaceutical and biotechnology sectors, we offer timely, effective counsel on a wide variety of matters. Continue Reading ». June 23rd, 2016. Posted in Global Comparisons. AIFA publishes “Second Concept Paper” on biosimilars. April 13th, 2015. By Hein van den Bos. Posted in Global Comparisons. Netherlands MEB revises position on biosimilars and interchangeability. April 16th, 2012. By Marie A. Vodicka. Posted in News and Events. While a Supreme Court ruling on the...
biosimilarslawblog.com
biosimilarity | Biosimilars Law Blog
http://www.biosimilarslawblog.com/tag/biosimilarity
With more than 100 lawyers serving the pharmaceutical and biotechnology sectors, we offer timely, effective counsel on a wide variety of matters. Continue Reading ». June 23rd, 2016. Posted in Global Comparisons. AIFA publishes “Second Concept Paper” on biosimilars. June 23rd, 2015. By Marie A. Vodicka. Posted in News and Events. FDA Updates U.S. Biosimilar Guidances. April 17th, 2015. By Marie A. Vodicka. Posted in News and Events. The First Biosimilar in the U.S. Five Questions Left Open by FDA. Last m...
biosimilarslawblog.com
FDA Biosimilars Guidances | Biosimilars Law Blog
http://www.biosimilarslawblog.com/tag/fda-biosimilars-guidances
With more than 100 lawyers serving the pharmaceutical and biotechnology sectors, we offer timely, effective counsel on a wide variety of matters. Continue Reading ». Tag Archives: FDA Biosimilars Guidances. July 15th, 2016. And Marie A. Vodicka. Posted in Biosimilar labeling. FDA Denies Three Petitions on Biosimilar Labeling: Refers Petitioners to Guidance Process. August 31st, 2015. By Marie A. Vodicka. Posted in Biosimilar Definitions. June 23rd, 2015. By Marie A. Vodicka. Posted in News and Events.
biosimilarslawblog.com
BPCIA | Biosimilars Law Blog
http://www.biosimilarslawblog.com/tag/bpcia
With more than 100 lawyers serving the pharmaceutical and biotechnology sectors, we offer timely, effective counsel on a wide variety of matters. Continue Reading ». March 16th, 2016. Marie A. Vodicka. Jason F. Conaty. Posted in Biosimilars Patent Exchange. FDA Guidance on Transition Biological Products: Implications for Exclusivity and Patent Listings. October 7th, 2014. Posted in Biosimilar Definitions. Hogan Lovells on Facebook. Hogan Lovells on Linkedin. Hogan Lovells on Twitter. Subscribe to this bl...
biosimilarslawblog.com
First Licensure | Biosimilars Law Blog
http://www.biosimilarslawblog.com/tag/first-licensure
With more than 100 lawyers serving the pharmaceutical and biotechnology sectors, we offer timely, effective counsel on a wide variety of matters. Continue Reading ». Tag Archives: First Licensure. October 7th, 2014. Posted in Biosimilar Definitions. FDA Issues Draft Guidances on Reference Product Exclusivity for Biological Products and Clinical Pharmacology for Biosimilars. Hogan Lovells on Facebook. Hogan Lovells on Linkedin. Hogan Lovells on Twitter. Subscribe to this blog via RSS. HL Chronicle of Data...
biosimilarslawblog.com
Biosimilar Definitions | Biosimilars Law Blog
http://www.biosimilarslawblog.com/biosimilar-definitions
With more than 100 lawyers serving the pharmaceutical and biotechnology sectors, we offer timely, effective counsel on a wide variety of matters. Continue Reading ». Category Archives: Biosimilar Definitions. Subscribe to Biosimilar Definitions RSS Feed. August 31st, 2015. By Marie A. Vodicka. Posted in Biosimilar Definitions. FDA Announces Policy for Unique Nonproprietary Names for Biologics and Biosimilars. October 7th, 2014. Posted in Biosimilar Definitions. May 22nd, 2013. Posted in Biosimilar Defini...
hlarbitrationlaw.com
The European Parliament Votes to Remove Investor-State Arbitration from the Trans-Atlantic Trade and Investment Partnership (TTIP) Negotiations | ARBlog
http://www.hlarbitrationlaw.com/2015/07/the-european-parliament-votes-to-remove-investor-state-arbitration-from-the-trans-atlantic-trade-and-investment-partnership-ttip-negotiations
International Arbitration News, Trends and Cases. Published by Hogan Lovells. The European Parliament Votes to Remove Investor-State Arbitration from the Trans-Atlantic Trade and Investment Partnership (TTIP) Negotiations. July 16th, 2015. The European Parliament Votes to Remove Investor-State Arbitration from the Trans-Atlantic Trade and Investment Partnership (TTIP) Negotiations. On 8 July 2015, the European Parliament voted favorably on a non-binding resolution that approves. By the European Parliamen...
